Janssen-Cilag International NV announced IONSYS (fentanyl iontophoretic transdermal system), a new needle-free system ...
January 29, 2008 - The Medicines Company received the European Commission�s authorization of an expanded use for ...
February 2008 - The body regulates its core temperature by reducing the blood flow to the extremities, but anesthesia ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
Power Medical Interventions Inc. said the FDA cleared its 510(k) application for marketing its intelligent iDrive ...
January 29, 2008 � A novel treatment for blood clots in the legs, in which injecting or �lacing� the clot with a ...
January 29, 2008 - Edwards Lifesciences Corp. received conditional approval from the FDA for the addition of the ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
NEC Electronics America Inc. introduced two new color, 21.3-inch diagonal amorphous-silicon thin-film transistor (TFT) liquid-crystal display (LCD) modules for medical imaging applications.
Cheetah Medical Inc. said the FDA cleared for marketing the Reliant, a portable cardiac output monitor that provides a noninvasive window to cardiac and hemodynamic function.
MEDecision Inc. introduced Alineo, a collaborative healthcare management platform for addressing case management, disease management and utilization management.
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
January 28, 2008 - Arbor Surgical Technologies Inc. closed a $20 million dollar Series C financing round led by ...
BD Diagnostics said it received clearance from the FDA for the BD GeneOhm StaphSR assay, which the company says is the first test to rapidly and simultaneously identify two deadly healthcare-associated infections (HAIs) - Staphylococcus aureus and Methicillin-resistant Staphylococcus aureus (MRSA) - from patients with positive blood cultures.
January 28, 2008 - Inverness Medical Innovations will acquire Matria Healthcare, Inc. for approximately $1.18 billion, consisting of approximately $900 million to acquire the Matria shares of common stock and assumption of approximately $280 million of Matria's indebtedness outstanding, which will further Inverness' approach of bringing its proprietary diagnostic products into the home.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
The FDA granted Ethicon Inc. an expanded indication for EVICEL Fibrin Sealant (Human), which is one of the first fibrin sealants available as an adjunct to hemostasis for use in surgery, when control of bleeding by standard surgical techniques is ineffective or impractical.
January 28, 2008 - Toshiba America Medical Systems Inc. said today the FDA cleared the new open-bore 1.5T Vantage Titan ...
Monitoring system maker Mennen Medical said an additional monitor, the VitaLogik 4000 Series, will soon be available for ...
January 28, 2008
